相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting the acetylation signaling pathway in cancer therapy
Fabin Dang et al.
SEMINARS IN CANCER BIOLOGY (2022)
HDAC11 Regulates Glycolysis through the LKB1/AMPK Signaling Pathway to Maintain Hepatocellular Carcinoma Stemness
Lei Bi et al.
CANCER RESEARCH (2021)
HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
Lanzhu Yue et al.
BLOOD (2020)
Clinical activity of programmed cell death 1 (PD-1) blockade in never, light, and heavy smokers with non-small-cell lung cancer and PD-L1 expression >= 50%
J. F. Gainor et al.
ANNALS OF ONCOLOGY (2020)
Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth
Maojin Yao et al.
CELL (2020)
Novel HDAC11 inhibitors suppress lung adenocarcinoma stem cell self-renewal and overcome drug resistance by suppressing Sox2
Namrata Bora-Singhal et al.
SCIENTIFIC REPORTS (2020)
LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axis
Qiang Fei et al.
CANCER CELL INTERNATIONAL (2020)
Promoter Hypomethylation and miR-145-5p Downregulation- Mediated HDAC11 Overexpression Promotes Sorafenib Resistance and Metastasis of Hepatocellular Carcinoma Cells
Wenlong Wang et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
HDAC11: a rising star in epigenetics
Shan-Shan Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Innate Immune Training of Granulopoiesis Promotes Anti-tumor Activity
Lydia Kalafati et al.
CELL (2020)
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers
Neal Ready et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Promoter conservation in HDACs points to functional implications
Toni A. Boltz et al.
BMC GENOMICS (2019)
Progression of Disease Within 24 Months in Follicular Lymphoma Is Associated With Reduced Intratumoral Immune Infiltration
Joshua W. D. Tobin et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Histone deacetylase 11 inhibition promotes breast cancer metastasis from lymph nodes
Patrick L. Leslie et al.
NATURE COMMUNICATIONS (2019)
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Daniel E. Johnson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Combination Therapies Targeting HDAC and IKK in Solid Tumors
Ivana Vancurova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
Regulated Polarization of Tumor-Associated Macrophages by miR-145 via Colorectal Cancer-Derived Extracellular Vesicles
Haruka Shinohara et al.
JOURNAL OF IMMUNOLOGY (2017)
Histone/protein deacetylase 11 targeting promotes Foxp3+Treg function
Jianbing Huang et al.
SCIENTIFIC REPORTS (2017)
T cells lacking HDAC11 have increased effector functions and mediate enhanced alloreactivity in a murine model
David M. Woods et al.
BLOOD (2017)
Gene signature of the post-Chernobyl papillary thyroid cancer
Daria Handkiewicz-Junak et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function
Eva Sahakian et al.
MOLECULAR IMMUNOLOGY (2015)
HDAC11 is a novel drug target in carcinomas
Hedwig E. Deubzer et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
Alejandro Villagra et al.
NATURE IMMUNOLOGY (2009)
Developmental expression of histone deacetylase 11 in the murine brain
Hedi Liu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2008)
Cloning and functional characterization of HDAC11, a novel member of the human histone deacetylase family
L Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
